ADC Therapeutics SA (NYSE:ADCT)

26.02
Delayed Data
As of 3:59pm ET
 -0.40 / -1.51%
Today’s Change
20.01
Today|||52-Week Range
38.34
-18.71%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for ADC Therapeutics SA have a median target of 44.00, with a high estimate of 55.00 and a low estimate of 33.00. The median estimate represents a +69.10% increase from the last price of 26.02.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in ADC Therapeutics SA. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.92
Sales
$7.4M
Reporting Date
Nov 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -31.02%
 
 
 
 
 
 
Growthannually -28.41%
 
 
 

Sales

Growthquarterly 96.43%
 
 
 
 
 
 
Growthannually --
 
 
 
Key to the earnings and sales forecast charts.